Addition of 3‐methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy

Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma

(2020) Graeme Eisenhofer et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma

(2019) Bílek et al.   Cancers

Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or DeconjugatedO-Methylated Catecholamine Metabolites

(2018) Graeme Eisenhofer et al.   CLINICAL CHEMISTRY

Clinical utility of chromogranin A for the surveillance of succinate dehydrogenase B- and succinate dehydrogenase D-related paraganglioma

(2018) Michael JW Thompson et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine

(2018) Graeme Eisenhofer et al.   CLINICA CHIMICA ACTA

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma

(2017) Dipti Rao et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma: Table 1

(2016) P F Plouin et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Clinical utility of chromogranin A inSDHx-related paragangliomas

(2014) Samuel Zuber et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline

(2014) Jacques W. M. Lenders et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites

(2013) N van Duinen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Quantifying the Effects of Renal Impairment on Plasma Concentrations of the Neuroendocrine Neoplasia Biomarkers Chromogranin A, Chromogranin B, and Cocaine- and Amphetamine-Regulated Transcript

(2012) P. R. Bech et al.   CLINICAL CHEMISTRY

Plasma and Urinary Metanephrines Determined by an Enzyme Immunoassay, but not Serum Chromogranin A for the Diagnosis of Pheochromocytoma in Patients with Adrenal Mass

(2012) N. Unger et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma

(2011) G. Eisenhofer et al.   CLINICAL CHEMISTRY

Performance of plasma free metanephrines measured by liquid chromatography–tandem mass spectrometry in the diagnosis of pheochromocytoma

(2010) Robert T. Peaston et al.   CLINICA CHIMICA ACTA

Plasma chromogranin A levels are increased in a small portion of patients with hereditary head and neck paragangliomas

(2010) Nicolette van Duinen et al.   CLINICAL ENDOCRINOLOGY

Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in theSuccinate Dehydrogenase Subunit BGene

(2008) Henri J. L. M. Timmers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma Chromogranin A or Urine Fractionated Metanephrines Follow-Up Testing Improves the Diagnostic Accuracy of Plasma Fractionated Metanephrines for Pheochromocytoma

(2007) Alicia Algeciras-Schimnich et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM